Pancreatic Cancer Research

ResearcherKyoto UniversityActive in the last 2 years

Yoshihiro Nishikawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1113-6937; OpenAlex author ID A5027722156. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. Impact of Stent Type on Surgical Outcomes in Pancreatic Cancer Patients Undergoing Preoperative Biliary Drainage. Co-author DOI 10.1111/den.70229↗
  2. ARF6-AMAP1 pathway induces pancreatic cancer cells to express immunosuppressive chemokines Co-author DOI 10.21203/rs.3.rs-1897319/v1↗
  3. Correction: CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-21-1255↗
  4. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-19-2745↗
  5. ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer. Co-author DOI 10.1073/pnas.1901765116↗
  6. Perfusion in the tissue surrounding pancreatic cancer and the patient's prognosis. Co-author DOI 10.1155/2014/648021↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuzo Kodama · 5 shared papers, 2014–2022 · strength 0.45
  2. Tomoaki Matsumori · 3 shared papers, 2020–2026 · strength 0.39
  3. Tsutomu Chiba · 3 shared papers, 2014–2021 · strength 0.24
  4. Akio Tsutaho · 2 shared papers, 2019–2022 · strength 0.22
  5. Ari Hashimoto · 2 shared papers, 2019–2022 · strength 0.22
  6. Hisataka Sabe · 2 shared papers, 2019–2022 · strength 0.22
  7. Satoshi Hirano · 2 shared papers, 2019–2022 · strength 0.22
  8. Shigeru Hashimoto · 2 shared papers, 2019–2022 · strength 0.22
  9. Akiko Tsujimoto · 1 shared paper, 2026 · strength 0.20
  10. Koh Kitagawa · 1 shared paper, 2026 · strength 0.20
  11. Yuki Ishikawa‐Kakiya · 1 shared paper, 2026 · strength 0.20
  12. Mamoru Takenaka · 1 shared paper, 2026 · strength 0.20
  13. Tsukasa Ikeura · 1 shared paper, 2026 · strength 0.20
  14. Tomoya Emori · 1 shared paper, 2026 · strength 0.20
  15. Atsuhiro Masuda · 1 shared paper, 2026 · strength 0.20
  16. Takashi Ito · 1 shared paper, 2026 · strength 0.20
  17. Toshifumi Doi · 1 shared paper, 2026 · strength 0.20
  18. Takuo Yamai · 1 shared paper, 2026 · strength 0.20
  19. Takashi Tamura · 1 shared paper, 2026 · strength 0.20
  20. Minako Nagai · 1 shared paper, 2026 · strength 0.20
  21. Takeshi Ogura · 1 shared paper, 2026 · strength 0.20
  22. Ippei Matsumoto · 1 shared paper, 2026 · strength 0.20
  23. Masayuki Kitano · 1 shared paper, 2026 · strength 0.20
  24. Toshihiro Morita · 2 shared papers, 2020–2021 · strength 0.18
  25. Takahisa Maruno · 2 shared papers, 2020–2021 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.